QUILLIVANT XR Trademark

Trademark Overview

On Wednesday, August 15, 2012, a trademark application was filed for QUILLIVANT XR with the United States Patent and Trademark Office. The USPTO has given the QUILLIVANT XR trademark a serial number of 85704149. The federal status of this trademark filing is REGISTERED AND RENEWED as of Monday, July 8, 2024. This trademark is owned by NextWave Pharmaceuticals, Inc.. The QUILLIVANT XR trademark is filed in the Pharmaceutical Products category with the following description:

Oral liquid suspension pharmaceutical preparations for the extended relief of central nervous system diseases and disorders and for the treatment of attention deficit hyperactivity disorder; methylphenidate hydrochloride in oral suspension liquid form for the extended relief of central nervous system diseases and disorders and for the treatment of attention deficit hyperactivity disorder
quillivant xr

General Information

Serial Number85704149
Word MarkQUILLIVANT XR
Filing DateWednesday, August 15, 2012
Status800 - REGISTERED AND RENEWED
Status DateMonday, July 8, 2024
Registration Number4511557
Registration DateTuesday, April 8, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 18, 2013

Trademark Statements

Goods and ServicesOral liquid suspension pharmaceutical preparations for the extended relief of central nervous system diseases and disorders and for the treatment of attention deficit hyperactivity disorder; methylphenidate hydrochloride in oral suspension liquid form for the extended relief of central nervous system diseases and disorders and for the treatment of attention deficit hyperactivity disorder
NOT AVAILABLE"XR"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 22, 2012
Primary Code005
First Use Anywhere DateMonday, January 14, 2013
First Use In Commerce DateMonday, January 14, 2013

Trademark Owner History

Party NameNextWave Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMonmouth Junction, NJ 08852
Party NameNextWave Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCupertino, CA 95014
Party NameNextWave Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCupertino, CA 95014

Trademark Events

Event DateEvent Description
Tuesday, December 11, 2012NON-FINAL ACTION E-MAILED
Saturday, August 18, 2012NEW APPLICATION ENTERED
Wednesday, August 22, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 11, 2012ASSIGNED TO EXAMINER
Tuesday, December 11, 2012NON-FINAL ACTION WRITTEN
Tuesday, December 11, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 16, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 29, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, December 13, 2012TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 13, 2012ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 2, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 7, 2013ASSIGNED TO LIE
Tuesday, May 14, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 14, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 14, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 18, 2013PUBLISHED FOR OPPOSITION
Thursday, February 27, 2014SOU EXTENSION 1 GRANTED
Tuesday, June 18, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 13, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, January 27, 2014TEAS STATEMENT OF USE RECEIVED
Monday, January 27, 2014SOU TEAS EXTENSION RECEIVED
Monday, January 27, 2014SOU EXTENSION 1 FILED
Monday, January 27, 2014USE AMENDMENT FILED
Monday, February 24, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, February 24, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, February 27, 2014STATEMENT OF USE PROCESSING COMPLETE
Thursday, February 27, 2014ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, March 1, 2014NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, February 28, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 28, 2014LAW OFFICE REGISTRATION REVIEW COMPLETED
Tuesday, April 8, 2014REGISTERED-PRINCIPAL REGISTER
Wednesday, October 3, 2018ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, February 5, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 5, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 8, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Saturday, April 8, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, April 8, 2024TEAS SECTION 8 & 9 RECEIVED
Tuesday, July 16, 2019TEAS SECTION 8 & 15 RECEIVED
Tuesday, July 16, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 26, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, August 26, 2019REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, August 26, 2019NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, July 5, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, July 8, 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Monday, July 8, 2024REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Monday, July 8, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Related Keywords

quillivant treatment disorders diseases attention deficit disorder hyperactivity oral system suspension